Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

CLINICAL REFERENCE LABORATORY, INC.

Filed by VENTURE GOVERNMENT STRATEGIES, LLC (FKA HOBART HALLAWAY & QUAYLE VENTURES, LLC).

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 19, 2025
Income
$20,000.00
Expenses
Not reported
Filing UUID
a3333dec-54e4-4e77-a3f9-f8e761094b1d
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MED · Medical/Disease Research/Clinical Labs

Policies and regulations impacting clinical laboratories and drug testing, including issues related to HHS and DOT; H.R.4320, Drug and Alcohol Clearinghouse Public Safety Improvement Act of 2025; DOT Rule 49 CFR Part 40 Section 40.82.

Literal federal measure citations: H.R.4320

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.